ATE125278T1 - Biologisch abbaubarer copolyester von 4- hydroxyprolin und diesen enthaltende pharmazeutische zusammensetzung. - Google Patents

Biologisch abbaubarer copolyester von 4- hydroxyprolin und diesen enthaltende pharmazeutische zusammensetzung.

Info

Publication number
ATE125278T1
ATE125278T1 AT92307924T AT92307924T ATE125278T1 AT E125278 T1 ATE125278 T1 AT E125278T1 AT 92307924 T AT92307924 T AT 92307924T AT 92307924 T AT92307924 T AT 92307924T AT E125278 T1 ATE125278 T1 AT E125278T1
Authority
AT
Austria
Prior art keywords
hydroxyproline
pharmaceutical composition
composition containing
containing same
biodegradable copolyester
Prior art date
Application number
AT92307924T
Other languages
English (en)
Inventor
Seiji Mochizuki
Kiyoshi Nawata
Yuji Makino
Yoshiki Suzuki
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE125278T1 publication Critical patent/ATE125278T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/685—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen
    • C08G63/6852—Polyesters containing atoms other than carbon, hydrogen and oxygen containing nitrogen derived from hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
AT92307924T 1991-09-06 1992-09-01 Biologisch abbaubarer copolyester von 4- hydroxyprolin und diesen enthaltende pharmazeutische zusammensetzung. ATE125278T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25429091 1991-09-06

Publications (1)

Publication Number Publication Date
ATE125278T1 true ATE125278T1 (de) 1995-08-15

Family

ID=17262915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92307924T ATE125278T1 (de) 1991-09-06 1992-09-01 Biologisch abbaubarer copolyester von 4- hydroxyprolin und diesen enthaltende pharmazeutische zusammensetzung.

Country Status (7)

Country Link
US (1) US5395916A (de)
EP (1) EP0531091B1 (de)
JP (1) JPH05202177A (de)
AT (1) ATE125278T1 (de)
DE (1) DE69203551T2 (de)
DK (1) DK0531091T3 (de)
ES (1) ES2074828T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6372880B1 (en) * 1997-12-25 2002-04-16 Mitsui Chemicals, Inc. Copolymer and process for preparing the same
AU6510400A (en) * 1999-08-04 2001-03-05 Oakwood Laboratories L.L.C. Slow release microspheres
US7265247B1 (en) 2006-07-28 2007-09-04 Im&T Research, Inc. Substituted phenylsulfur trifluoride and other like fluorinating agents
US8399720B2 (en) * 2007-03-23 2013-03-19 Ube Industries, Ltd. Methods for producing fluorinated phenylsulfur pentafluorides
KR20140061493A (ko) * 2007-03-23 2014-05-21 우베 인더스트리즈 리미티드 아릴설퍼 펜타플루오라이드의 제조공정
US8030516B2 (en) * 2007-10-19 2011-10-04 Ube Industries, Ltd. Methods for producing perfluoroalkanedi(sulfonyl chloride)
WO2009076345A1 (en) * 2007-12-11 2009-06-18 Im & T Research, Inc. Methods and compositions for producing difluoromethylene-and trifluoromethyl-containing compounds
TW201006787A (en) * 2008-03-07 2010-02-16 Im & T Res Inc Fluorination processes with arylsulfur halotetrafluorides
CN102186812A (zh) * 2008-08-18 2011-09-14 宇部兴产株式会社 制备氟烷基芳基亚磺酰基化合物及其氟化的化合物的方法
EP2334661B1 (de) * 2008-09-22 2017-08-30 Ube Industries, Ltd. Verfahren zur herstellung aromatischer poly(pentafluorsulfanyl)-verbindungen
US20100174096A1 (en) * 2009-01-05 2010-07-08 Im&T Research, Inc. Methods for Production of Optically Active Fluoropyrrolidine Derivatives
US8203003B2 (en) 2009-01-09 2012-06-19 Ube Industries, Ltd. 4-fluoropyrrolidine-2-carbonyl fluoride compounds and their preparative methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
USRE30170E (en) * 1975-04-04 1979-12-18 Sutures, Inc. Hydrolyzable polymers of amino acid and hydroxy acids
US4428939A (en) * 1981-10-16 1984-01-31 Prockop Darwin J Collagen inhibiting compositions and processes for manufacturing and using same
JPS61172813A (ja) * 1985-01-28 1986-08-04 Japan Atom Energy Res Inst ポリ乳酸を担体とする徐放性複合体の製造方法
JPH0720859B2 (ja) * 1985-02-07 1995-03-08 武田薬品工業株式会社 マイクロカプセルの製造法
US4831107A (en) * 1986-07-28 1989-05-16 Semih Erhan Polymer preparation from lysine and a quinone
JPS6341416A (ja) * 1986-08-08 1988-02-22 Takeda Chem Ind Ltd 鎮痛性ペプチド含有マイクロカプセルの製造法
JP2702729B2 (ja) * 1988-02-24 1998-01-26 エーザイ株式会社 徐放性埋込剤
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer

Also Published As

Publication number Publication date
EP0531091A1 (de) 1993-03-10
JPH05202177A (ja) 1993-08-10
EP0531091B1 (de) 1995-07-19
DK0531091T3 (da) 1995-09-11
DE69203551T2 (de) 1996-01-11
ES2074828T3 (es) 1995-09-16
DE69203551D1 (de) 1995-08-24
US5395916A (en) 1995-03-07

Similar Documents

Publication Publication Date Title
ES2149537T3 (es) Resina intercambiadora de aniones no reticulados y composicion farmaceutica que contiene la misma.
ATE125278T1 (de) Biologisch abbaubarer copolyester von 4- hydroxyprolin und diesen enthaltende pharmazeutische zusammensetzung.
ATE114304T1 (de) Aminoalkylindole, verfahren zu deren herstellung und diese enthaltende pharmazeutische präparate.
CA2235996A1 (en) New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
IE893653L (en) Compositions and compounds
DE69031913T2 (de) Antivirale mittel
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
AU626095B2 (en) Hydroxyalkane carboxylic acid derivatives, their production and use
DE69224613D1 (de) Peptide, Herstellung und deren Verwendung
ES2000865A6 (es) Procedimiento para la obtencion de derivados del acido 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilico
GR3003472T3 (en) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ATE36154T1 (de) 4-phenylaminopyridin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
IL106564A (en) Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them
EP0459624A3 (en) Galactosamine-substituted poly-omega-substituted-l-glutamic and/or-aspartic acid
HUT62284A (en) Process for producing n-cycloalkylamine derivatives and pharmaceutical compositions comprising such compounds as active ingredient
ATE7141T1 (de) Neue substituierte 4-amino-2,6-diaryltetrahydrothiopyrane, deren saeureadditionssalze, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
SE8802162L (sv) Nya aminoacylater av glycerolacetal
IT1248068B (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ES2068685T3 (es) Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos.